Litcius/Paper detail

Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone

Atsushi Natsume, Kosuke Aoki, Fumiharu Ohka, Sachi Maeda, Masaki Hirano, Alimu Adilijiang, Kazuya Motomura, Minako Sumi, Ryo Nishikawa, Yoshitaka Narita, Yoshihiro Muragaki, Takashi Maruyama, Tamio Ito, Takaaki Beppu, Hideo Nakamura, Takamasa Kayama, Shinya Sato, Motoo Nagane, Kazuhiko Mishima, Yoko Nakasu, Kaoru Kurisu, Fumiyuki Yamasaki, Kazuhiko Sugiyama, Takanori Onishi, Yasuo Iwadate, Mizuhiko Terasaki, Hiroyuki Kobayashi, Akira Matsumura, Eiichi Ishikawa, Hikaru Sasaki, Akitake Mukasa, Takayuki Matsuo, Hirofumi Hirano, Toshihiro Kumabe, Nobusada Shinoura, Naoya Hashimoto, Tomokazu Aoki, Akio Asai, Tatsuya Abé, Atsuo Yoshino, Yoshiki Arakawa, Kenichiro Asano, Koji Yoshimoto, Soichiro Shibui, Yusuke Okuno, Toshihiko Wakabayashi

2020Journal of Neuro-Oncology11 citationsDOI

Topics & Concepts

TemozolomideO-6-methylguanine-DNA methyltransferaseHazard ratioMicrosatellite instabilityOncologySanger sequencingInternal medicineGliomaCancer researchMedicineCpG siteBiologyMutationMethylationDNA methylationConfidence intervalMethyltransferaseGeneticsGeneMicrosatelliteAlleleGene expressionGlioma Diagnosis and TreatmentBrain Metastases and TreatmentMeningioma and schwannoma management
Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone | Litcius